WT1 Antikörper (AA 1-302)

Produktnummer ABIN3021698

Produktdetails anti-WT1 Antikörper

Target: WT1 (Wilms Tumor 1 (WT1))

Bindungsspezifität: AA 1-302

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser WT1 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Sequenz: MEKGYSTVTF DGTPSYGHTP SHHAAQFPNH SFKHEDPMGQ QGSLGEQQYS VPPPVYGCHT PTDSCTGSQA LLLRTPYSSD NLYQMTSQLE CMTWNQMNLG ATLKGVAAGS SSSVKWTEGQ SNHSTGYESD NHTTPILCGA QYRIHTHGVF RGIQDVRRVP GVAPTLVRSA SETSEKRPFM CAYPGCNKRY FKLSHLQMHS RKHTGEKPYQ CDFKDCERRF SRSDQLKRHQ RRHTGVKPFQ CKTCQRKFSR SDHLKTHTRT HTGEKPFSCR WPSCQKKFAR SDELVRHHNM HQRNMTKLQL AL

Kreuzreaktivität: Human, Maus, Ratte

Produktmerkmale: Polyclonal Antibodies

Immunogen: Recombinant fusion protein containing a sequence corresponding to amino acids 1-302 of human WT1 (NP_001185480.1).

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB,1:500 - 1:2000

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Avoid freeze / thaw cycles

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C. Avoid freeze / thaw cycles.

Referenzen für anti-WT1 Antikörper (ABIN3021698)

Wang, Luo, Du, Shu, Guo, Li: "Nuclear paraspeckle assembly transcript 1 promotes the podocyte injury via targeting miR-23b-3p/B-cell lymphoma-2 interacting protein 3 like axis." in: Renal failure, Vol. 44, Issue 1, pp. 1961-1975, (2022) (PubMed).

Details zu WT1

Target: WT1 (Wilms Tumor 1 (WT1))

Andere Bezeichnung: WT1 (WT1 Produkte)

Synonyme: AWT1 antikoerper, EWS-WT1 antikoerper, GUD antikoerper, NPHS4 antikoerper, WAGR antikoerper, WIT-2 antikoerper, WT33 antikoerper, CWT1 antikoerper, WT1 antikoerper, XWT1a antikoerper, wt-1 antikoerper, wt1 antikoerper, xWT1 antikoerper, WT-1 antikoerper, gud antikoerper, wagr antikoerper, wt33 antikoerper, xwt1 antikoerper, wit-2 antikoerper, si:ch211-160j6.3 antikoerper, zgc:152697 antikoerper, D630046I19Rik antikoerper, Wt-1 antikoerper, XWT1b antikoerper, XeWT1 antikoerper, Wilms tumor 1 antikoerper, Wilms tumor 1 S homeolog antikoerper, wilms tumor 1b antikoerper, Wilms tumor protein antikoerper, Wilms tumor 1 homolog antikoerper, Wilms tumor 1 L homeolog antikoerper, WT1 antikoerper, wt1.S antikoerper, wt1 antikoerper, wt1b antikoerper, Wt1 antikoerper, wt1.L antikoerper

Hintergrund: This gene encodes a transcription factor that contains four zinc-finger motifs at the C-terminus and a proline/glutamine-rich DNA-binding domain at the N-terminus. It has an essential role in the normal development of the urogenital system, and it is mutated in a small subset of patients with Wilms tumor. This gene exhibits complex tissue-specific and polymorphic imprinting pattern, with biallelic, and monoallelic expression from the maternal and paternal alleles in different tissues. Multiple transcript variants have been described. In several variants, there is evidence for the use of a non-AUG (CUG) translation initiation codon upstream of, and in-frame with the first AUG. Authors of PMID:7926762 also provide evidence that WT1 mRNA undergoes RNA editing in human and rat, and that this process is tissue-restricted and developmentally regulated.,WT1,AWT1,EWS-WT1,GUD,NPHS4,WAGR,WIT-2,WT33,Epigenetics & Nuclear Signaling,Transcription Factors,Cancer,Tumor biomarkers,Signal Transduction,ErbB-HER Signaling Pathway,Cell Biology & Developmental Biology,Apoptosis,WT1

Molekulargewicht: 33 kDa/34 kDa/47 kDa/48 kDa/49 kDa/55 kDa/56 kDa

Gen-ID: 7490

UniProt: P19544

Pathways: Tube Formation